| NDC Code | 51662-1457-1 |
|---|
| Package Description | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM (51662-1457-1) |
|---|
| Product NDC | 51662-1457 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Diltiazem Hci |
|---|
| Non-Proprietary Name | Diltiazem Hci |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20191215 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA075853 |
|---|
| Manufacturer | HF Acquisition Co LLC, DBA HealthFirst |
|---|
| Substance Name | DILTIAZEM HYDROCHLORIDE |
|---|
| Strength | 100 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA] |
|---|